Journal of Pharmacogenomics & Pharmacoproteomics

da Cruz, João Paulo Garcia Lopes. Impacto da farmacogenética na farmacocinética dos antirretrovíricos em doentes coinfetados por vírus da imunodeficiência humana (VIH) e vírus da hepatite B (VHB) e/ou vírus da hepatite C (VHC). Diss. UNIVERSIDADE DE LISBOA, 2015.

Montes Ares, Olga. "Sistema HLA y factores farmacogenéticos en la evolución de la infección por VIH-1 en pacientes de Las Palmas de Gran Canaria." (2016).

Montes Ares, Olga. "Sistema HLA y factores farmacogenéticos en la evolución de la infección por VIH-1 en pacientes de Las Palmas de Gran Canaria." (2016).

Nwogu, Jacinta Nwamaka, et al. "Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of Antiretrovirals." AIDS research and treatment 2016 (2016).

Nwogu, Jacinta Nwamaka, et al. "Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of Antiretrovirals." AIDS research and treatment 2016 (2016).

Morse, Gene D., and Babafemi Taiwo. "Pharmacokinetic, Pharmacogenetic and other factors influencing CNS penetration of antiretrovirals."

Hernández Arroyo, María Jesús, et al. "A pharmacist’s role in the individualization of treatment of HIV patients." Personalized Medicine 13.2 (2016): 169-188.

Dalal, Bhavik, Aruna Shankarkumar, and K. Ghosh. "Individualization of antiretroviral therapy-Pharmacogenomic aspect." The Indian journal of medical research 142.6 (2015): 663.

Shah, Viral N., and Viswanathan Mohan. "Diabetes in India: what is different?." Current Opinion in Endocrinology, Diabetes and Obesity 22.4 (2015): 283-289.

Ha, Sung-Kyu. "ACE insertion/deletion polymorphism and diabetic nephropathy: clinical implications of genetic information." Journal of diabetes research 2014 (2014).

Claudio-Campos, Karla, et al. "Pharmacogenetics of healthy volunteers in Puerto Rico." Drug metabolism and personalized therapy 30.4 (2015): 239-249.

Roy III, A. Kenison, Chenen Hsieh, and Kathleen Crapanzano. "Dextromethorphan Addiction Mediated Through the NMDA System: Common Pathways With Alcohol?." Journal of addiction medicine 9.6 (2015): 499-501.

Vanichakarn, P., J. Hwa, and J. Stitham. "Cardiovascular pharmacogenetics of antihypertensive and lipid-lowering therapies." Current molecular medicine 14.7 (2014): 849-879.

Lan, Tian, et al. "Effects of CYP2C19 variants on methadone metabolism in vitro." Drug testing and analysis (2016).

Dai, Da-Peng, et al. "In vitro functional analysis of 24 novel CYP2C19 variants recently found in the Chinese Han population." Xenobiotica 45.11 (2015): 1030-1035.

Duconge, Jorge, et al. "A novel admixture-based pharmacogenetic approach to refine warfarin dosing in Caribbean Hispanics." PloS one 11.1 (2016): e0145480.

Claudio-Campos, Karla, et al. "Pharmacogenetics of drug-metabolizing enzymes in US Hispanics." Drug metabolism and personalized therapy 30.2 (2015): 87-105.

Céspedes-Garro, Carolina, et al. "Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes." Expert opinion on drug metabolism & toxicology 11.12 (2015): 1893-1905.

Fricke-Galindo, I., et al. "Interethnic variation of CYP2C19 alleles,‘predicted’phenotypes and ‘measured’metabolic phenotypes across world populations." The pharmacogenomics journal 16.2 (2016): 113-123.

LLerena, Adrián, et al. "Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations." Expert opinion on drug metabolism & toxicology 10.11 (2014): 1569-1583.